Japan Agency for Medical Research and Development

23F Yomiuri Shimbun Bldg. 1-7-1 Otemachi, Chiyoda-Ku , 1000004 Tokyo
Japan

Telephone +81 3 68702212
Fax +81 3 68702242
hideyuki-asano@amed.go.jp

This company is main exhibitor of

Trade fair hall

  • Hall 16 / B49
 Interactive Plan

Hall map

MEDICA 2016 hall map (Hall 16): stand B49

Fairground map

MEDICA 2016 fairground map: Hall 16

About us

Company details

The Japan Agency for Medical Research and Development (AMED) engages in research and development in the field of medicine, establishing and maintaining an environment for this R&D, and providing funding, in order to promote integrated medical R&D from basic research to practical applications, to smoothly achieve application of outcomes, and to achieve comprehensive and effective establishment / maintenance of an environment for medical R&D.

The role of AMED

Providing a one-stop service for research expenses, AMED consolidates budgets for research expenses, which had previously been allocated from different sources -- the Ministry of Education, Culture, Sports, Science and Technology, the Ministry of Health, Labour and Welfare, and the Ministry of Economy, Trade and Industry. In addition to making possible an integrated approach to providing research funding and establishing / maintaining research environments, the unification of points of contact and procedures for research expenses can be expected to reduce the administrative burden on institutions and researchers receiving allocations for research expenses. AMED aims to achieve the world's highest level of medical care / service and to form a society in which people live long, healthy lives by promoting integrated research and development, from basic research to practical application, and by establishing and maintaining an environment therefor, and linking this to various forms of growth in medical R&D.

AMED operations

(1) Engaging in medical R&D and establishment / maintenance of medical research environment
(2) Promotion of the widespread adoption / practical utilization of outcomes related to (1)
(3) Provision of subsidies for medical R&D and establishment / maintenance of research environment
(4) Operations incidental to (1) through (3)

More Less